Literature DB >> 25972613

The Hamilton Rating Scale for Depression.

Rachel Sharp.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25972613     DOI： 10.1093/occmed/kqv043

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN： 0962-7480            Impact factor:   1.611


× No keyword cloud information.
  16 in total

1.  Abnormal Dynamic Functional Network Connectivity Estimated from Default Mode Network Predicts Symptom Severity in Major Depressive Disorder.

Authors:  Mohammad S E Sendi; Elaheh Zendehrouh; Jing Sui; Zening Fu; Dongmei Zhi; Luxian Lv; Xiaohong Ma; Qing Ke; Xianbin Li; Chuanyue Wang; Christopher C Abbott; Jessica A Turner; Robyn L Miller; Vince D Calhoun
Journal:  Brain Connect       Date:  2021-11-23

2.  Cognitive Vulnerabilities as Prognostic Predictors of Acute and Follow-up Outcomes in Seasonal Affective Disorder Treatment with Light Therapy or Cognitive-Behavioral Therapy.

Authors:  Julia A Camuso; Kelly J Rohan
Journal:  Cognit Ther Res       Date:  2020-03-02

3.  Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).

Authors:  Eleonora Dalla Bella; Irene Tramacere; Giovanni Antonini; Giuseppe Borghero; Margherita Capasso; Claudia Caponnetto; Adriano Chiò; Massimo Corbo; Roberto Eleopra; Massimiliano Filosto; Fabio Giannini; Enrico Granieri; Vincenzo La Bella; Christian Lunetta; Jessica Mandrioli; Letizia Mazzini; Sonia Messina; Maria Rosaria Monsurrò; Gabriele Mora; Nilo Riva; Romana Rizzi; Gabriele Siciliano; Vincenzo Silani; Isabella Simone; Gianni Sorarù; Paolo Volanti; Giuseppe Lauria
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

4.  Cortical thickness and subcortical structure volume abnormalities in patients with major depression with and without anxious symptoms.

Authors:  Ke Zhao; Haiyan Liu; Rui Yan; Lingling Hua; Yu Chen; Jiabo Shi; Qing Lu; Zhijian Yao
Journal:  Brain Behav       Date:  2017-06-27       Impact factor: 2.708

5.  Efficacy and safety of electroacupuncture for post stroke depression: study protocol for a randomized controlled trial.

Authors:  Wa Cai; Wen Ma; Guan-Tao Wang; Wei-Dong Shen
Journal:  Trials       Date:  2018-03-02       Impact factor: 2.279

6.  Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial.

Authors:  Jingjing Zhou; Weiwei Wang; Jian Yang; Xuequan Zhu; Lei Feng; Le Xiao; Gang Wang
Journal:  Trials       Date:  2019-01-09       Impact factor: 2.279

7.  The impact of SARS-CoV-2 on the mental health of healthcare workers in a hospital setting-A Systematic Review.

Authors:  Jaspinder Sanghera; Nikhil Pattani; Yousuf Hashmi; Kate F Varley; Manikandar Srinivas Cheruvu; Alex Bradley; Joshua R Burke
Journal:  J Occup Health       Date:  2020-01       Impact factor: 2.708

Review 8.  Antidepressant medication during pregnancy and epigenetic changes in umbilical cord blood: a systematic review.

Authors:  Anne-Cathrine F Viuff; Lars Henning Pedersen; Kasper Kyng; Nicklas Heine Staunstrup; Anders Børglum; Tine Brink Henriksen
Journal:  Clin Epigenetics       Date:  2016-09-07       Impact factor: 6.551

9.  Dynamic Functional Connectivity Predicts Treatment Response to Electroconvulsive Therapy in Major Depressive Disorder.

Authors:  Hossein Dini; Mohammad S E Sendi; Jing Sui; Zening Fu; Randall Espinoza; Katherine L Narr; Shile Qi; Christopher C Abbott; Sanne J H van Rooij; Patricio Riva-Posse; Luis Emilio Bruni; Helen S Mayberg; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2021-07-06       Impact factor: 3.169

10.  Effects of electroacupuncture therapy for depression: Study protocol for a multicentered, randomized controlled trial.

Authors:  Wa Cai; Wen Ma; Ai-Wen Chen; Wei-Dong Shen
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.